Device type · MYL
Assay,Enzyme Linked Immunosorbent,Parvovirus B19 Igg
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MYL
Microbiology
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Assay,Enzyme Linked Immunosorbent,Parvovirus B19 Igg
- Product code
- MYL
- Device class
- Class III
- Review panel
- Microbiology
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for MYL
Latest FDA decisions
P220034 · Decided Mar 29, 2024 · 458 days after receipt
Device type: ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG (MYL) · Laboratory Medicine & Pathology
P150045 · Decided Sep 19, 2017 · 665 days after receipt
Device type: ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG (MYL) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0602-2024 · Started Oct 31, 2023 · Posted by FDA Dec 21, 2023
Reason given: The organization completed a product improvement process to the conjugate found within the certain ELISA kits. This modification was not reviewed and approved by FDA prior to its implementation.
Cause as FDA categorized it: Device Design
Z-0603-2024 · Started Oct 31, 2023 · Posted by FDA Dec 21, 2023
Reason given: The organization completed a product improvement process to the conjugate found within the certain ELISA kits. This modification was not reviewed and approved by FDA prior to its implementation.
Cause as FDA categorized it: Device Design
- Parvovirus B19 IgG EIA kit Part No. V519IGUSOpen, Classified
Z-2936-2020 · Started Jul 17, 2020
Reason given: Printed label inside the box lid of the Parvovirus has the incorrect Lot Specific Constant value
Cause as FDA categorized it: Under Investigation by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.